Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income
AI Summary
StalkThe stock remains in a Stage 2 advancing regime with a bullish medium-term bias supported by rising 50- and 200-day SMAs and higher lows, but recent bullish exhaustion at resistance and flattening short EMAs make immediate entries unfavorable. We will stalk for pullbacks into the rising 9/20 EMAs or the 50-day SMA support zone for controlled entries.